166 related articles for article (PubMed ID: 38032469)
1. Integration of single-cell transcriptomics and epigenetic analysis reveals enhancer-controlled TIMP1 as a regulator of ferroptosis in colorectal cancer.
Li M; Ni QY; Yu SY
Genes Genomics; 2024 Jan; 46(1):121-133. PubMed ID: 38032469
[TBL] [Abstract][Full Text] [Related]
2. Role of stemness-related genes TIMP1, PGF, and SNAI1 in the prognosis of colorectal cancer through single-cell RNA-seq.
Shen Y; Ni S; Li S; Lv B
Cancer Med; 2023 May; 12(10):11611-11623. PubMed ID: 37017587
[TBL] [Abstract][Full Text] [Related]
3. Construction of a New Ferroptosis-related Prognosis Model for Survival Prediction in Colorectal Cancer.
Chen L; Ge M; Mo S; Shi M; Zhang J; Liu J
Curr Med Chem; 2024 Feb; ():. PubMed ID: 38362684
[TBL] [Abstract][Full Text] [Related]
4. TIMP1 represses sorafenib-triggered ferroptosis in colorectal cancer cells by activating the PI3K/Akt signaling pathway.
Wang L; Wang J; Chen L
Immunopharmacol Immunotoxicol; 2023 Dec; 45(4):419-425. PubMed ID: 36541209
[TBL] [Abstract][Full Text] [Related]
5. Aberrant activation of CYR61 enhancers in colorectal cancer development.
Xie L; Song X; Lin H; Chen Z; Li Q; Guo T; Xu T; Su T; Xu M; Chang X; Wang LK; Liang B; Huang D
J Exp Clin Cancer Res; 2019 May; 38(1):213. PubMed ID: 31118064
[TBL] [Abstract][Full Text] [Related]
6. Unraveling TIMP1: a multifaceted biomarker in colorectal cancer.
Qiu X; Quan G; Ou W; Wang P; Huang X; Li X; Shen Y; Yang W; Wang J; Wu X
Front Genet; 2023; 14():1265137. PubMed ID: 37842645
[No Abstract] [Full Text] [Related]
7. Comprehensive Omics Analysis of a Novel Small-Molecule Inhibitor of Chemoresistant Oncogenic Signatures in Colorectal Cancer Cell with Antitumor Effects.
Huang TH; Mokgautsi N; Huang YJ; Wu ATH; Huang HS
Cells; 2021 Aug; 10(8):. PubMed ID: 34440739
[TBL] [Abstract][Full Text] [Related]
8. TIMP1 promotes cell proliferation and invasion capability of right-sided colon cancers via the FAK/Akt signaling pathway.
Ma B; Ueda H; Okamoto K; Bando M; Fujimoto S; Okada Y; Kawaguchi T; Wada H; Miyamoto H; Shimada M; Sato Y; Takayama T
Cancer Sci; 2022 Dec; 113(12):4244-4257. PubMed ID: 36073574
[TBL] [Abstract][Full Text] [Related]
9. Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies.
Firouzjaei AA; Aghaee-Bakhtiari SH; Tafti A; Sharifi K; Abadi MHJN; Rezaei S; Mohammadi-Yeganeh S
Cell Biochem Funct; 2023 Dec; 41(8):1488-1502. PubMed ID: 38014635
[TBL] [Abstract][Full Text] [Related]
10. The identification of a common different gene expression signature in patients with colorectal cancer.
Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of basement membrane-related gene based on single-cell and bulk RNA sequencing data to predict prognosis and evaluate immune characteristics in colorectal cancer.
Han J; Wang Q; Li S; Yang J; Qiu Z; Fu W
Environ Toxicol; 2024 Jun; 39(6):3367-3380. PubMed ID: 38445432
[TBL] [Abstract][Full Text] [Related]
12. Silencing LCN2 enhances RSL3-induced ferroptosis in T cell acute lymphoblastic leukemia.
Tian C; Zheng M; Lan X; Liu L; Ye Z; Li C
Gene; 2023 Aug; 879():147597. PubMed ID: 37390872
[TBL] [Abstract][Full Text] [Related]
13. SNORA56-mediated pseudouridylation of 28 S rRNA inhibits ferroptosis and promotes colorectal cancer proliferation by enhancing GCLC translation.
Xu C; Bian Z; Wang X; Niu N; Liu L; Xiao Y; Zhu J; Huang N; Zhang Y; Chen Y; Wu Q; Sun F; Zhu X; Pan Q
J Exp Clin Cancer Res; 2023 Dec; 42(1):331. PubMed ID: 38049865
[TBL] [Abstract][Full Text] [Related]
14. B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer.
Jin H; Zhu M; Zhang D; Liu X; Guo Y; Xia L; Chen Y; Chen Y; Xu R; Liu C; Xi Q; Xia S; Shi T; Zhang G
Cancer Sci; 2023 Nov; 114(11):4225-4236. PubMed ID: 37661645
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients.
Du S; Zeng F; Sun H; Liu Y; Han P; Zhang B; Xue W; Deng G; Yin M; Cui B
Bioengineered; 2022 Feb; 13(2):2498-2512. PubMed ID: 35067161
[TBL] [Abstract][Full Text] [Related]
16. Enhancer-driven transcription of MCM8 by E2F4 promotes ATR pathway activation and glioma stem cell characteristics.
Sun YM; Zhang YM; Shi HL; Yang S; Zhao YL; Liu HJ; Li C; Liu HL; Yang JP; Song J; Sun GZ; Yang JK
Hereditas; 2023 Jun; 160(1):29. PubMed ID: 37349788
[TBL] [Abstract][Full Text] [Related]
17. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
[TBL] [Abstract][Full Text] [Related]
18. Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer.
Yang YB; Zhou JX; Qiu SH; He JS; Pan JH; Pan YL
Dis Markers; 2021; 2021():4846683. PubMed ID: 34868393
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism rs2682818 participates in the progression of colorectal carcinoma via miR-618-TIMP1 regulatory axis.
Shao W; Xia H; Lan Q; Gu J; Huang H; Zheng F; Zheng Y
Sci Rep; 2021 Nov; 11(1):23186. PubMed ID: 34848810
[TBL] [Abstract][Full Text] [Related]
20. Exosomal MEF2C's Association With the Progression of CRC in Regulating CD36 Transcription.
Wang M; Jiang Y; Fan ZL; Zhang N; Liang J; Zheng Z
Altern Ther Health Med; 2023 Jan; 29(1):198-209. PubMed ID: 36074971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]